Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1D
Clinical trial NCT03841526 · COMPLETED
Trial details
- NCT number
- NCT03841526
- Sponsor
- Xeris Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-22
- Primary completion
- 2020-04-02
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.